Bioo | GenomeWeb

Bioo

The company said it will use the proceeds for various purposes, including working capital, capital expenditures, stock repurchases, dividends, and acquisitions.

Revenues rose thank to an increase in the company's human health business, which offset a decline in its environmental health segment.

Bioo licensed technology to reduce ligation bias in NGS and has incorporated it into its RNA-seq library prep kit.

Bioo Scientific has launched the NextFlex Cell Free DNA-Seq kit for preparing Illumina libraries from low amounts of circulating tumor DNA or cell-free fetal DNA. According to the company, the kit can be used with 1 nanogram of DNA to construct libraries within two hours or less.

Lab7 Systems has released a beta version of its next-generation sequencing data workflow management software platform, available for download to early-access users from the company's website. The company is planning updates to the software every four to six weeks.

An analysis aimed at establishing a baseline understanding of the small, exosome-bound RNAs present in typical blood samples is also offering insights into the performance of the existing methods used to make libraries of the small RNAs found within the membrane-bound vesicles.

DNAStar has released Lasergene 11, sequence assembly software that is available both in the Amazon Cloud and on desktop computers. Other improvements include the new application MegAlignPro and enhanced copy number variation analysis capability.

Roche has launched SeqCap EZ Reagent kits, which include the accessory, oligonucleotides, hybridization, and wash kits configured in a 24-reaction pack.

Bioo Scientific has introduced two new products for siRNA delivery into leukocytes: huLeukoAim, for use in human cells, and muLeukoAim, for use in mouse cells.

Pages

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.